Australasian anaesthesia 2025: invited papers and selected continuing education lectures

Lim E; Doane M [editor]; Szental J; Hamblin S; Dennis AT [editor]

AIRR - ANZCA Institutional Research Repository

Please use this identifier to cite or link to this item: https://hdl.handle.net/11055/1383

Full metadata record

DC Field	Value	Language
dc.contributor.author	Lim E	en_US
dc.contributor.author	Doane M [editor]	en_US
dc.contributor.author	Szental J	en_US
dc.contributor.author	Hamblin S	en_US
dc.contributor.author	Dennis AT [editor]	en_US
dc.date	2025-11-11	-
dc.date.accessioned	2025-09-16T04:54:26Z	-
dc.date.available	2025-09-16T04:54:26Z	-
dc.date.issued	2025-11-11	-
dc.identifier.uri	https://hdl.handle.net/11055/1383	-
dc.description	Glucagon like peptide-1 receptor agonists (GLP-1 RA) are a new class of medication that has recently emerged. GLP-1 RA are being prescribed to an increasing number of patients for the treatment of diabetes and/or obesity. This article explores the history of GLP-1 RA development, current perioperative management guidelines, controversies and future directions. Additionally, it discusses how the medical community recognises and adapts to the evolving landscape of perioperative medication management, and the current status of GLP-1 RA in this journey.	en_US
dc.publisher	Australian and New Zealand College of Anaesthetists	en_US
dc.title	Australasian anaesthesia 2025: invited papers and selected continuing education lectures	en_US
dc.title.alternative	GLP-1 receptor agonists – an evolving paradigm in perioperative medication management	en_US
dc.type	Book Chapter	en_US
dc.type.content	Text	en_US
dc.publisher.place	Melbourne	en_US
dc.identifier.doi	10.60115/11055/1383	en_US
dc.type.specialty	Anaesthesia	en_US
item.grantfulltext	open	-
item.openairecristype	http://purl.org/coar/resource_type/c_18cf	-
item.openairetype	Book Chapter	-
item.cerifentitytype	Publications	-
item.fulltext	With Fulltext	-
Appears in Collections:	Corporate